Showing results (351-360 of 515) with videos related to
Sort By:
Pageof 52
Crohn'S & Colitis 360|June 9, 2023
Utility of Intestinal Ultrasound in Clinical Decision-Making for Inflammatory Bowel DiseaseAdam Saleh, Bincy P AbrahamCrohn'S & Colitis 360|June 8, 2023
Usefulness of Serum Leucine-rich Alpha 2 Glycoprotein in Crohn's Disease: Is There Any Difference between Small Intestine and Colonic Lesions?Satohiro Matsumoto, Hirosato MashimaCrohn'S & Colitis 360|October 9, 2023
Bedside Intestinal Ultrasound Performed in an Inflammatory Bowel Disease Urgent Assessment Clinic Improves Clinical Decision-Making and Resource UtilizationJoëlle St-Pierre, Maxime Delisle, Hengameh Kheirkhahrahimabadi, et al.Crohn'S & Colitis 360|September 18, 2023
Integrating Intestinal Ultrasound into an Inflammatory Bowel Disease Practice: How to Get StartedBincy P Abraham, Dheeraj Reddy, Adam SalehCrohn'S & Colitis 360|September 8, 2023
Tixagevimab and Cilgavimab (Evusheld) as Pre-exposure Prophylaxis for COVID-19 in Patients With Inflammatory Bowel Disease: A Propensity Matched Cohort StudyAakash Desai, Jana G Hashash, Gursimran S Kochhar, et al.Crohn'S & Colitis 360|March 3, 2026
Local prevalence and management of Janus kinase inhibitor-induced acne among adolescents with inflammatory bowel diseaseAnna Isabella Shanker Barclay, Caroline H T Hall, Carla Torres-Zegarra, et al.Crohn'S & Colitis 360|March 17, 2026
Impact of missing patient report outcomes in clinical trials for ulcerative colitis: Should we always assume treatment failure?Yihao Li, Jiahe Li, Michael E Rothenberg, et al.Crohn'S & Colitis 360|March 16, 2026
Transabdominal intestinal ultrasound versus transmural histopathological findings in severe ulcerative colitis requiring colectomyHiromu Morikubo, Jun Miyoshi, Akimasa Hayashi, et al.Crohn'S & Colitis 360|April 24, 2026
Influenza vaccine uptake among patients with inflammatory bowel disease: comparable outcomes between telemedicine and in-person careMazen Almasry, Trevor L Schell, Luke Richard, et al.Crohn'S & Colitis 360|April 24, 2026
Efficacy and safety of ABBV-154 in patients with moderately to severely active Crohn's disease: a phase 2b, randomized, double-blind, placebo-controlled trialWalter Reinisch, Laurent Peyrin-Biroulet, Geert D'Haens, et al.Pageof 52